|
35 Companies |
|
34 Products |
|
34 Products |
|
43 Mechanisms of Action |
|
0 Trials |
|
224 News |
|
| «12345 |
- |||| Enrollment open: Safety and Efficacy of IZN-6N4 Oral Rinse for the Prevention of Oral Mucositis in Patients With Head and Neck Cancer (clinicaltrials.gov) - May 22, 2012
P2, N=110, Recruiting, Sponsor: Izun Pharma Ltd
Not yet recruiting --> Recruiting
- Trial initiation date: Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation Therapy (clinicaltrials.gov) - May 8, 2012
P=N/A, N=0, Withdrawn, Sponsor: M.D. Anderson Cancer Center
Not yet recruiting --> Recruiting Initiation date: Apr 2012 --> Nov 2012
- Zyclara (imiquimod) / Mochida, Viatris, Bausch Health
Biomarker, New P2 trial: Identification of Novel Biomarkers of Cervicovaginal Mucosal Inflammation (clinicaltrials.gov) - May 3, 2012
P2, N=39, Completed, Sponsor: CONRAD
- Enrollment change: The Effect of Honey on Xerostomia and Oral Mucositis (clinicaltrials.gov) - Apr 25, 2012
P2, N=60, Recruiting, Sponsor: Cyprus University of Technology
Initiation date: Apr 2012 --> Nov 2012 N=40 --> 60
- ||| Enrollment change: A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients (clinicaltrials.gov) - Apr 18, 2012
P4, N=120, Completed, Sponsor: Access Pharmaceuticals, Inc.
N=40 --> 60 N=80 --> 120
- || Humira (adalimumab) / AbbVie
New P3 trial: ADACAL: Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn's Disease Treated With Immunosuppressants (clinicaltrials.gov) - Mar 22, 2012
P3, N=160, Recruiting, Sponsor: Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
- Kepivance (palifermin) / SOBI, Amgen
Trial completion: Dose Escalation Study Of Palifermin in Pediatric Research Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (clinicaltrials.gov) - Mar 21, 2012
P1, N=19, Completed, Sponsor: St. Jude Children's Research Hospital
N=80 --> 120 Active, not recruiting --> Completed
- Enrollment change: Oral Mucositis in Patients Undergoing Antineoplastic Chemotherapy (clinicaltrials.gov) - Mar 20, 2012
P=N/A, N=4, Completed, Sponsor: University of Arkansas
Active, not recruiting --> Completed N=15 --> 4
- Trial completion: Oral Mucositis in Patients Undergoing Antineoplastic Chemotherapy (clinicaltrials.gov) - Mar 20, 2012
P=N/A, N=4, Completed, Sponsor: University of Arkansas
N=15 --> 4 Recruiting --> Completed
- ifosfamide / Generic mfg., cisplatin / Generic mfg., doxorubicin hydrochloride / Generic mfg.
Trial completion: Caphosol in Sarcoma Patients With Mucositis (clinicaltrials.gov) - Mar 19, 2012
P2, N=30, Completed, Sponsor: M.D. Anderson Cancer Center
Recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: Nutritional Status and Barriers to Dietary Intake in Head and Neck Cancer Patients (clinicaltrials.gov) - Mar 18, 2012
P=N/A, N=100, Completed, Sponsor: AHS Cancer Control Alberta
Active, not recruiting --> Completed Recruiting --> Completed
- TXA-127 / Constant Therap
New P2 trial: Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood Transplantation (clinicaltrials.gov) - Mar 12, 2012
P2, N=0, Withdrawn, Sponsor: US Biotest, Inc.
- Kepivance (palifermin) / SOBI, Amgen, peripheral blood stem cell transplantation / National Cancer Institute
Enrollment change: Melphalan and Palifermin in Treating Patients Undergoing An Autologous Peripheral Stem Cell Transplant for Stage II or III Multiple Myeloma (clinicaltrials.gov) - Mar 7, 2012
P1, N=38, Completed, Sponsor: Barbara Ann Karmanos Cancer Institute
Recruiting --> Completed N=30 --> 38
- |||||||||| New P3 trial: CD2 Lozenges in Preventing Acute Oral Mucositis in Patients With Head and Neck Cancer Receiving Radiotherapy and Chemotherapy (clinicaltrials.gov) - Feb 29, 2012
P3, N=148, Not yet recruiting, Sponsor: North Central Cancer Treatment Group
- amifostine / Generic mfg.
Trial termination: Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia (clinicaltrials.gov) - Dec 6, 2011
P2, N=42, Terminated, Sponsor: Vanderbilt-Ingram Cancer Center
N=30 --> 38 Active, not recruiting --> Terminated; funding became unavailable
- Kepivance (palifermin) / SOBI, Amgen
Enrollment change: A Phase 1 Dose-escalation Study to Evaluate the Safety and Pharmacokinetics (PK) of Palifermin in Subjects With Acute Leukemias Undergoing HSCT (clinicaltrials.gov) - Nov 30, 2011
P1, N=27, Completed, Sponsor: Swedish Orphan Biovitrum
Active, not recruiting --> Terminated; funding became unavailable N=54 --> 27
- | Kepivance (palifermin) / SOBI, Amgen
Trial completion: A Phase 1 Dose-escalation Study to Evaluate the Safety and Pharmacokinetics (PK) of Palifermin in Subjects With Acute Leukemias Undergoing HSCT (clinicaltrials.gov) - Nov 30, 2011
P1, N=27, Completed, Sponsor: Swedish Orphan Biovitrum
N=54 --> 27 Active, not recruiting --> Completed
- New P2 trial: A Pilot Study of Efficacy of Lactobacillus CD2 Lozenges in Preventing High-dose Chemotherapy Induced Oral Mucositis in Patients Undergoing Hematopoietic Stem Cell Transplantation (clinicaltrials.gov) - Nov 24, 2011
P2, N=31, Completed, Sponsor: All India Institute of Medical Sciences, New Delhi
- | New P2 trial: The Effect of Honey on Xerostomia and Oral Mucositis (clinicaltrials.gov) - Nov 2, 2011
P2, N=60, Recruiting, Sponsor: Cyprus University of Technology
- New P2 trial: Honey in Chronic Immune Thrombocytopenia (clinicaltrials.gov) - Oct 20, 2011
P2, N=30, Not yet recruiting, Sponsor: mamdouh abdulmaksoud abdulrhman
- || New P3 trial: Low-level Laser Therapy to Prevent Oral Mucositis in Head and Neck Patients (clinicaltrials.gov) - Sep 21, 2011
P3, N=94, Completed, Sponsor: Instituto Nacional de Cancer, Brazil
- | New P2 trial: Honey and a Mixture of Honey, Beeswax and Olive Oil-propolis Extract in Treatment of Chemotherapy-induced Oral Mucositis (clinicaltrials.gov) - Sep 7, 2011
P2, N=90, Completed, Sponsor: mamdouh abdulmaksoud abdulrhman
- ||||| New P2 trial, HEOR, Cost effectiveness: Pharmaco-economic Study of a New Medical Device Performed From the Perspective of the Hospital (clinicaltrials.gov) - Aug 29, 2011
P2, N=92, Completed, Sponsor: Nantes University Hospital